This announcement is a separate document:
中信证券股份有限公司关于上海凯赛生物技术股份有限公司首次公开发行股票并在科创板上市持续督导保荐总结报告书
CITIC Securities Co., Ltd. summary report on Shanghai Kaisai Biotechnology Co., Ltd.'s initial public offering of shares and continued supervision and sponsorship of its listing on the Science and Technology Innovation Board
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.